Pharmaceutical composition comprising a GLP-1 agonist, an insulin and methionine

US10029011B2 · kind B2 · utility

Assignee

• Sanofi-Aventis Deutschland GMBH · DE

Inventors

• Annika Hagendorf · Hattersheim, DE
• Gerrit Hauck · Frankfurt am Main, DE
• Werner Mueller · Cologne, DE
• Isabell Schoettle · Frankfurt am Main, DE
• Verena Siefke-Henzler · Frankfurt, DE
• Katrin Tertsch · Frankfurt am Main, DE

Key dates

• Filing date: Nov 11, 2010
• Grant date: Jul 24, 2018
• Expiry date: Nov 11, 2030

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K14/62
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A liquid composition comprising a GLP-1 agonist or/and a pharmacologically tolerable salt thereof, an insulin or/and a pharmacologically tolerable salt thereof, and, optionally, at least one pharmaceutically acceptable excipient, wherein the composition comprises methionine, as add-on therapy with metformin where appropriate.